Indo-Bangla Pharmaceuticals Limited (DSE:IBP)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
11.80
-0.30 (-2.48%)
At close: Dec 4, 2025
29.67%
Market Cap 1.37B
Revenue (ttm) 91.10M
Net Income (ttm) -46.01M
Shares Out 116.21M
EPS (ttm) -0.32
PE Ratio n/a
Forward PE n/a
Dividend 0.01 (0.08%)
Ex-Dividend Date Dec 8, 2025
Volume 870,644
Average Volume 787,316
Open 12.10
Previous Close 12.10
Day's Range 11.70 - 12.10
52-Week Range 8.40 - 15.60
Beta 0.09
RSI 51.02
Earnings Date Oct 29, 2025

About DSE:IBP

Indo-Bangla Pharmaceuticals Limited engages in the manufacture and sale of various medicines, medical preparations drugs, and chemicals in Bangladesh and internationally. Its principal products include analgesics and antipyretics, anthelmintic, anti-asthmatic, gastroprokinetic and antiemetic, antiprotozoal, non-hormone sex stimulant, non-steroidal, anti-inflammatory, steroids, and vitamins and minerals, as well as respiratory, cardiovascular, central nervous system, dermatology, and gastrointestinal categories. The company markets its products ... [Read more]

Industry Pharmaceutical Preparations
Founded 1954
Employees 152
Stock Exchange Dhaka Stock Exchange
Ticker Symbol IBP
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.